Peer-reviewed journal (1-3 of 3)

1. Why We Need Continuous Pharmaceutical Manufacturing and How to Make It Happen

   0.0 out of 5 stars 

   09 Jun 2023 | Contributor(s):: Clive Badman, Charles L.Cooney, Alastair Florence, Konstantin Konstantinov, Markus Krumme, Salvatore Mascia, Moheb Nasr, Bernhardt L. Trout

   We make the case for why continuous pharmaceutical manufacturing is essential, what the barriers are, and how to overcome them. To overcome them, government action is needed in terms of tax incentives or regulatory incentives that affect time.

2. Continuous manufacturing technologies in upstream pharmaceutical supply chains: Combining engineering and managerial criteria

   0.0 out of 5 stars 

   09 Jun 2023 | Contributor(s):: Aulakh, PK, Settanni, E, Srai, JS

   The COVID-19 pandemic exposed vulnerabilities in upstream pharmaceutical supply chains (PSC). One is that the global supply of active pharmaceutical ingredients (APIs) is overly dependent on few locations and large-scale batch manufacturing. Regulators hope to enable more dependable location...

3. Advanced Pharmaceutical Manufacturing: A Functional Definition

   0.0 out of 5 stars 

   09 Jun 2023 | Contributor(s):: Romañach, Rodolfo J., Stelzer, Torsten, Sanchez, Eric, Muzzio, Fernando

   The term “Advanced Pharmaceutical Manufacturing” (APM) has become an ubiquitous buzzword with deep potential policy implications. There is a real danger that APM will be seen as a general panacea for solving economic woes and drug shortages, devoiding it from specific meaning, and depriving the...